deCODE genetics (Nasdaq:DCGN) today announced that
its presentation at the C.E. Unterberg, Towbin Life
Sciences Conference on Tuesday, October 31, 2006, will
be webcast live. The presentation will be delivered
at 10am Eastern Time/3pm GMT at the Palace Hotel in
New York.
The webcast can be accessed through the Investors
page on deCODE’s website, www.decode.com. Those interested
in listening should log on a few minutes in advance
in order to download any software or complete any sign-in
that may be required.
About deCODE
deCODE genetics (NASDAQ:DCGN) is a global leader in applying human genetics
to develop drugs for common diseases. Our population approach has enabled
us to discover and target key biological pathways involved in conditions
ranging from heart attack to cancer. We are turning these discoveries into
new medicine to better treat and prevent many of the biggest challenges to
public health. deCODE is delivering on the promise of the new genetics.SM
Visit us on the web at www.decode.com.
Any statements contained in this presentation that relate to future plans,
events or performance are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, among others, those relating
to technology and product development, integration of acquired businesses,
market acceptance, government regulation and regulatory approval processes,
intellectual property rights and litigation, dependence on collaborative relationships,
ability to obtain financing, competitive products, industry trends and other
risks identified in deCODE’s filings with the Securities and Exchange Commission.
deCODE undertakes no obligation to update or alter these forward-looking statements
as a result of new information, future events or otherwise.
